Plenty of questions about #coronavirus on $SNY's call this morning. CEO Paul Hudson says it's always a bit "serendipitous" testing existing drugs for a new use. The company is currently studying Kevzara in #Covid19 treatment. #stocks #investingnews #pharmaceuticals